Skip to main content
. 2016 Jun 30;7(31):49289–49298. doi: 10.18632/oncotarget.10334

Figure 3. AR status predicts prognosis in endometrial cancer.

Figure 3

Endometrial cancer patients with AR expression (scoring index 1–9) have a significantly better survival than patient with AR loss (scoring index 0) both in the whole population (A) and in the subgroup of patients with FIGO stage I and II (B).